Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2012 | 2 |
2013 | 1 |
2017 | 1 |
2020 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The trispecific DARPin ensovibep inhibits diverse SARS-CoV-2 variants.
Nat Biotechnol. 2022 Dec;40(12):1845-1854. doi: 10.1038/s41587-022-01382-3. Epub 2022 Jul 21.
Nat Biotechnol. 2022.
PMID: 35864170
Free PMC article.
Targeting extracellular domains D4 and D7 of vascular endothelial growth factor receptor 2 reveals allosteric receptor regulatory sites.
Hyde CA, Giese A, Stuttfeld E, Abram Saliba J, Villemagne D, Schleier T, Binz HK, Ballmer-Hofer K.
Hyde CA, et al. Among authors: villemagne d.
Mol Cell Biol. 2012 Oct;32(19):3802-13. doi: 10.1128/MCB.06787-11. Epub 2012 Jul 16.
Mol Cell Biol. 2012.
PMID: 22801374
Free PMC article.
Review.
Item in Clipboard
Half-life extension using serum albumin-binding DARPin® domains.
Steiner D, Merz FW, Sonderegger I, Gulotti-Georgieva M, Villemagne D, Phillips DJ, Forrer P, Stumpp MT, Zitt C, Binz HK.
Steiner D, et al. Among authors: villemagne d.
Protein Eng Des Sel. 2017 Sep 1;30(9):583-591. doi: 10.1093/protein/gzx022.
Protein Eng Des Sel. 2017.
PMID: 29088432
Item in Clipboard
Profound Functional Suppression of Tumor-Infiltrating T-Cells in Ovarian Cancer Patients Can Be Reversed Using PD-1-Blocking Antibodies or DARPin® Proteins.
Foord E, Klynning C, Schoutrop E, Förster JM, Krieg J, Mörtberg A, Müller MR, Herzog C, Schiegg D, Villemagne D, Fiedler U, Snell D, Kebble B, Mattsson J, Levitsky V, Uhlin M.
Foord E, et al. Among authors: villemagne d.
J Immunol Res. 2020 Aug 4;2020:7375947. doi: 10.1155/2020/7375947. eCollection 2020.
J Immunol Res. 2020.
PMID: 32832572
Free PMC article.
Item in Clipboard
Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications.
Stahl A, Stumpp MT, Schlegel A, Ekawardhani S, Lehrling C, Martin G, Gulotti-Georgieva M, Villemagne D, Forrer P, Agostini HT, Binz HK.
Stahl A, et al. Among authors: villemagne d.
Angiogenesis. 2013 Jan;16(1):101-11. doi: 10.1007/s10456-012-9302-0. Epub 2012 Sep 15.
Angiogenesis. 2013.
PMID: 22983424
Free PMC article.
Item in Clipboard
Highly efficient ribosome display selection by use of purified components for in vitro translation.
Villemagne D, Jackson R, Douthwaite JA.
Villemagne D, et al.
J Immunol Methods. 2006 Jun 30;313(1-2):140-8. doi: 10.1016/j.jim.2006.04.001. Epub 2006 May 11.
J Immunol Methods. 2006.
PMID: 16730021
Item in Clipboard
Cite
Cite